Cardiac Features and Effects of Enzyme Replacement Therapy in Taiwanese Patients with Mucopolysaccharidosis IVA

Hsiang-Yu Lin,Ming-Ren Chen,Shan-Miao Lin,Chung-Lieh Hung,Dau-Ming Niu,Chih-Kuang Chuang,Shuan-Pei Lin
DOI: https://doi.org/10.1186/s13023-018-0883-6
2018-01-01
Orphanet Journal of Rare Diseases
Abstract:Cardiac abnormalities have been observed in patients with mucopolysaccharidosis (MPS) of any type, with the most documented abnormalities being valvular heart disease and cardiac hypertrophy. However, few studies have focused on the cardiac features of MPS IVA.
What problem does this paper attempt to address?